MServices/ Pipelines & Platforms
▪ Generative AI for Drug Discovery ▪ In Vivo CAR-M mRNA-LNP Therapy for Solid Tumors ▪ Eye Drop Formulation for the Dry Age-Related Macular Degeneration ▪ iPSC, iMSC Derived Exosome ▪ Enrichment and Detection of Exosomes ▪ Exosome Production Chip for Nucleic Acid Delivery
ITRI's one-stop biomedical services: ▪ R&D/ Prototyping ▪ Technology Licensing ▪ Preclinical/Clinical Trial ▪ GXP trial production ▪ Regulation Consulting
▪ Next-Gen Drug Discovery Platform ▪ Leading Exosome Application Platform
Business Interests
Out-Licensing, Collaborative R&D, CDMO, Clinical Trial Collaboration, Co-Development, Strategic Alliance
Contact Info
Sing Lin Administrator +886-3-582-0100 ITRI_BDL@itri.org.tw